PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.51%
Negative net income growth while MCHP stands at 24.12%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.38%
Some D&A expansion while MCHP is negative at -2.46%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-5666.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-8.82%
Both cut yoy SBC, with MCHP at -7.66%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-105.20%
Both reduce yoy usage, with MCHP at -153.25%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-3.33%
Both yoy AR lines negative, with MCHP at -356.76%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-72.20%
Both reduce yoy inventory, with MCHP at -31.88%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-19.05%
Negative yoy AP while MCHP is 68.65%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-11.29%
Negative yoy usage while MCHP is 5.41%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-117.24%
Negative yoy while MCHP is 5.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-26.17%
Both yoy CFO lines are negative, with MCHP at -12.39%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-22.41%
Both yoy lines negative, with MCHP at -26.35%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
15.14%
Purchases growth of 15.14% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
20.34%
Liquidation growth of 20.34% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-120.00%
We reduce yoy other investing while MCHP is 77.75%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
51.40%
We have mild expansions while MCHP is negative at -12.98%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
214.96%
We repay more while MCHP is negative at -5.14%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-35.90%
Negative yoy issuance while MCHP is 70.80%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
14.86%
We have some buyback growth while MCHP is negative at -56.39%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.